the,drug,been,european,could,agency,has,submitted,africa,have,dramatic,survival,t-vec,iii,international,conducted,company,amgen,both,patients,
fda,showing,treatment,favourable,drugs,food,april,opinion,oncology,cancer,research,kevin,amgen,developed,clinical,
medicines,inoperable,regulators,talimogene,laherparepvec,jump,phase,company,soon,europe,patients,approval,the,
manufactures,biopharmaceutical,funded,journal,are,company,afterwards,next,already,the,
the,t-vec,trial,approved,which,made,injection,receive,advanced,melanoma,randomly,large,length,london,institute,professor,amgen,year,patients,years,
